Screening for lung cancer: The guidelines

Peter B. Bach, Dennis E. Niewoehner, William C. Black

Research output: Contribution to journalReview articlepeer-review

83 Scopus citations


Although virtually all individuals with advanced lung cancer succumb to the disease, a substantial portion of individuals diagnosed at an earlier stage can be cured. This dichotomy has provoked interest in lung cancer screening. To date, randomized controlled trials of chest x-ray and sputum cytology have failed to demonstrate that screening with either modality decreases lung cancer mortality; neither of these technologies can be recommended. Early studies of lung cancer screening with low-dose CT (LDCT) appear promising; however, only data from observational studies are available. We recommend that individuals should only be screened with LDCT in the context of well-designed clinical trials.

Original languageEnglish (US)
Pages (from-to)83S-88S
Issue number1 SUPPL.
StatePublished - Jan 1 2003


  • Evidence-based medicine
  • Lung neoplasms
  • Mass chest x-ray
  • Mass screening
  • Practice guideline
  • Sputum
  • Tomography, x-ray computed


Dive into the research topics of 'Screening for lung cancer: The guidelines'. Together they form a unique fingerprint.

Cite this